Harrow to present Phase 3 BYQLOVI post-cataract inflammation trial data at AAO 2026
HROW•Harrow flagged 15 clinical research presentations across AAOpt 2026 and AAO 2026, including Phase 3 BYQLOVI data on post-operative inflammation and pain control after cataract surgery. AAOpt runs Sept. 30–Oct. 3, 2026, and AAO runs Oct. 9–12, 2026.
1. Conference presentations
Harrow said it flagged 15 clinical research presentations across AAOpt 2026 and AAO 2026. AAO posters on BYQLOVI will highlight Phase 3 cataract-surgery data on post-operative inflammation and pain control, with an emphasis on safety.
